Quest Diagnostics reports Q3 EPS $2.17, adjusted $2.36; raises 2022 guidance on base business growth of 5.1%

QUEST DIAGNOSTICS INC

2022-Q3 EPS reported $7.05 revenue$7,550,000,000

Q3 2022 net revenues $2.49B, down 10.4% YoY; base business revenues $2.17B, up 5.1% YoY; COVID-19 testing $316M, down 55.4%.
Reported diluted EPS $2.17 (down 46.0%); adjusted diluted EPS $2.36 (down 40.4%).
Full-year 2022 guidance raised: net revenues $9.72B-$9.86B; adjusted EPS $9.75-$9.95 (prior $9.55-$9.95).
CEO transition: Jim Davis becomes CEO and President on Nov 1; Steve Rusckowski becomes Executive Chairman through March 2023.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.